quinazolines has been researched along with Depressive Disorder, Major in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adams, P; Bruder, G; Buckner, R; Carmody, TJ; Cooper, C; Fava, M; Grannemann, BD; Kraemer, HC; Kurian, BT; McGrath, PJ; McInnis, M; Morris, DW; Ogden, RT; Oquendo, MA; Parsey, RV; Petkova, E; Phillips, ML; Pizzagalli, D; Toups, M; Trivedi, MH; Weissman, MM; Weyandt, S | 1 |
1 trial(s) available for quinazolines and Depressive Disorder, Major
| Article | Year |
|---|---|
Establishing moderators and biosignatures of antidepressant response in clinical care (EMBARC): Rationale and design.
Topics: Adult; Antidepressive Agents; Biomarkers; Brain; Depressive Disorder, Major; Double-Blind Method; Electroencephalography; Female; Humans; Magnetic Resonance Imaging; Male; Patient Selection; Precision Medicine; Psychiatric Status Rating Scales; Quinazolines; Research Design; Sertraline; Treatment Outcome | 2016 |